Brazil: Food and Drugs Law

The Brazilian Patent and Trademark Office (BRPTO) and Peru's INDECOPI have launched a collaborative examination initiative for patent applications in pharmaceuticals, biotechnology, and natural products. This partnership, formalized through a 2025 Bilateral Cooperation Memorandum, will provide expedited technical examination for qualifying PCT applications that entered the national phase between October 2022 and July 2023.

Brazil's food and drug regulatory agency Anvisa has initiated administrative proceedings to review advertising regulations for medicines and food products, responding to constitutional challenges...

This page appears to be a security verification checkpoint that temporarily blocks access while validating the incoming request. The system implements protective measures to distinguish legitimate users from automated traffic or potential security threats.

Brazil's Drug Market Regulation Chamber has introduced significant modifications to its drug pricing framework through Rule #7/2026, adjusting criteria for new drugs, biosimilars, and generic medications. The regulatory changes simplify documentation requirements for biosimilars while clarifying provisions for generic drug pricing, though several industry concerns regarding off-label treatment comparisons and retroactive application remain unresolved.

Explore the latest regulatory updates impacting Brazil's pharmaceutical, healthcare, cosmetics, and medical device industries in June. From ANVISA's new pharmacovigilance system to CFM's platform against medical practice violations, discover how these changes create both compliance challenges and strategic opportunities for industry stakeholders.

O Ministério da Agricultura e Pecuária (MAPA) implementou novas restrições ao uso de antimicrobianos na alimentação animal e produtos veterinários, além de lançar o SISPA, sistema digital unificado para processos de registro de agrotóxicos. Mudanças regulatórias também afetam o setor de bebidas lácteas, com prorrogação de prazos de adequação até junho de 2027.

On April 3, 2025, Brazil's Secretariat of Foreign Trade published Circular No. 25 of April 2, 2025, initiating an antidumping (AD) investigation of Brazilian imports of PET resin originating from Malaysia and Vietnam.

A má compreensão do papel de aplicativos como BlaBlaCar, iFood e Airbnb pode dar ensejo a decisões que geram insegurança jurídica...

To date, 2024 has not yet seen the type of mega-merger (Pfizer/Seagen) or level of agency enforcement (Sanofi/Maze or Amgen/Horizon) as 2023. But two notable investigations — one still active — show...